SofiaSante Pharmaceuticals develops advanced transdermal drug delivery systems for novel therapeutics, focusing on enhancing drug permeation and bioavailability. Their proprietary patch technology and formulation techniques are designed to improve the efficacy of peptide-based treatments, particularly for obesity and metabolic disorders.
Funding
Funding not disclosed
Founders
Product
Problem
Developing effective transdermal drug delivery systems for novel therapeutics, particularly for obesity, presents significant formulation and pharmacokinetic challenges. Existing delivery methods often struggle with consistent drug permeation and bioavailability, hindering the potential of advanced pharmaceutical compounds.
Solution
SofiaSante Pharmaceuticals is advancing a pipeline of innovative treatments by developing next-generation transdermal drug delivery systems. The company focuses on optimizing drug permeation and bioavailability for therapeutics, with a primary emphasis on obesity treatments. Through strategic collaborations and a commitment to scientific innovation, SofiaSante aims to enhance the efficacy and patient experience of pharmaceutical compounds. Their approach integrates advanced material science with pharmaceutical formulation to create advanced delivery platforms.
Target Audience
The primary target audience includes pharmaceutical companies seeking advanced drug delivery solutions for their therapeutic pipelines, particularly those focused on metabolic diseases.
Features
- Novel transdermal patch technology designed for enhanced drug permeation.
- Proprietary formulation techniques to improve pharmacokinetic profiles of active pharmaceutical ingredients.
- Focus on developing delivery systems for peptide-based therapeutics.
- Collaboration with research institutions for R&D of advanced drug delivery platforms.
- Development of systems targeting metabolic and endocrine disorders, including obesity.